Madrigal Pharmaceuticals Inc (MDGL)
331.32
+11.74
(+3.67%)
USD |
NASDAQ |
Nov 04, 16:00
334.40
+3.08
(+0.93%)
Pre-Market: 08:53
Madrigal Pharmaceuticals Market Cap: 7.226B for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 7.226B |
| November 01, 2024 | 6.970B |
| October 31, 2024 | 5.656B |
| October 30, 2024 | 4.710B |
| October 29, 2024 | 4.750B |
| October 28, 2024 | 4.733B |
| October 25, 2024 | 4.594B |
| October 24, 2024 | 4.426B |
| October 23, 2024 | 4.415B |
| October 22, 2024 | 4.440B |
| October 21, 2024 | 4.555B |
| October 18, 2024 | 4.676B |
| October 17, 2024 | 4.590B |
| October 16, 2024 | 4.701B |
| October 15, 2024 | 4.714B |
| October 14, 2024 | 4.698B |
| October 11, 2024 | 4.670B |
| October 10, 2024 | 4.592B |
| October 09, 2024 | 4.599B |
| October 08, 2024 | 4.727B |
| October 07, 2024 | 4.685B |
| October 04, 2024 | 4.545B |
| October 03, 2024 | 4.505B |
| October 02, 2024 | 4.561B |
| October 01, 2024 | 4.565B |
| Date | Value |
|---|---|
| September 30, 2024 | 4.628B |
| September 27, 2024 | 4.612B |
| September 26, 2024 | 4.644B |
| September 25, 2024 | 4.695B |
| September 24, 2024 | 4.843B |
| September 23, 2024 | 4.901B |
| September 20, 2024 | 5.070B |
| September 19, 2024 | 5.260B |
| September 18, 2024 | 5.063B |
| September 17, 2024 | 5.067B |
| September 16, 2024 | 5.068B |
| September 13, 2024 | 5.250B |
| September 12, 2024 | 5.097B |
| September 11, 2024 | 5.059B |
| September 10, 2024 | 5.117B |
| September 09, 2024 | 5.183B |
| September 06, 2024 | 5.296B |
| September 05, 2024 | 5.341B |
| September 04, 2024 | 5.327B |
| September 03, 2024 | 5.133B |
| August 30, 2024 | 5.366B |
| August 29, 2024 | 5.400B |
| August 28, 2024 | 5.445B |
| August 27, 2024 | 5.533B |
| August 26, 2024 | 5.554B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
927.76M
Minimum
Apr 03 2020
7.226B
Maximum
Nov 04 2024
2.674B
Average
1.799B
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals Inc | 2.425B |
| Sarepta Therapeutics Inc | 11.74B |
| ADMA Biologics Inc | 4.454B |
| Intra-Cellular Therapies Inc | 9.135B |
| Entrada Therapeutics Inc | 660.48M |
Market Cap Related Metrics
| PEG Ratio | -0.4316 |
| Price to Book Value | 9.298 |
| Price | 331.32 |
| Earnings Yield | -7.58% |
| PEGY Ratio | -0.4316 |